Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Centre Randomised Clinical Trial of Biomarker-Driven Maintenance Treatment for First-Line Metastatic Colorectal Cancer (MODUL)

NCT02291289 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT02291289
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02291289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Centre Randomised Clinical Trial of Biomarker-Driven Maintenance Treatment for First-Line Metastatic Colorectal Cancer (MODUL)
Lead sponsor
Hoffmann-La Roche
Phase
Phase 2
Overall status
Completed
Start date
April 17, 2015
Completion date
March 24, 2021
Enrollment
1,044 (actual)
Sites
154

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer